4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-002707
Chief Commercial Officer sold 29,159 shares at $0.45 ($13,241)
- Chief Commercial Officer acquired 74,773 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baldry Mark Chief Commercial Officer | 2025-01-23 | Grant or award | +74,773 | 123,282 | D | ||
| Baldry Mark Chief Commercial Officer | 2025-01-24 | Sale | −29,159 | $0.45 | $13,241 | 94,123 | D |
| Open-market sales · 29,159 sh · avg $0.45 · $13,241 | |||||||
Loading xslF345X05/wk-form4_1738019726.xml…